BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 24607815)

  • 41. Joint analysis of three European nested case-control studies of lung cancer among radon exposed miners: exposure restricted to below 300 WLM.
    Hunter N; Muirhead CR; Tomasek L; Kreuzer M; Laurier D; Leuraud K; Schnelzer M; Grosche B; Placek V; Heribanova A; Timarche M
    Health Phys; 2013 Mar; 104(3):282-92. PubMed ID: 23361424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The radon risk in Lombardy].
    Facchini U; Sesana L; Agostoni G; Testa V
    Radiol Med; 1997 Oct; 94(4):376-84. PubMed ID: 9465246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design issues in studies of radon and lung cancer: implications of the joint effect of smoking and radon.
    Upfal M; Divine G; Siemiatycki J
    Environ Health Perspect; 1995 Jan; 103(1):58-63. PubMed ID: 7628427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lung cancer risk from radon in Ontario, Canada: how many lung cancers can we prevent?
    Peterson E; Aker A; Kim J; Li Y; Brand K; Copes R
    Cancer Causes Control; 2013 Nov; 24(11):2013-20. PubMed ID: 23982909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incorporating uncertainty in aggregate burden of disease measures: an example of DALYs-averted by a smoking cessation campaign in the UK.
    de Vocht F; Higgerson J; Oliver K; Verma A
    J Epidemiol Community Health; 2011 Sep; 65(9):751-6. PubMed ID: 21097808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histology and smoking history of lung cancer cases and implications for prevention in Thailand.
    Limsila T; Mitacek EJ; Caplan LS; Brunnemann KD
    Prev Med; 1994 Mar; 23(2):249-52. PubMed ID: 8047533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BEIR VI radon: The rest of the story.
    Zarnke AM; Tharmalingam S; Boreham DR; Brooks AL
    Chem Biol Interact; 2019 Mar; 301():81-87. PubMed ID: 30763549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The costs of radon mitigation in domestic properties.
    Coskeran T; Denman A; Phillips P
    Health Policy; 2001 Aug; 57(2):97-109. PubMed ID: 11395177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-benefit analyses of radon mitigation projects.
    Petersen ML; Larsen T
    J Environ Manage; 2006 Oct; 81(1):19-26. PubMed ID: 16616412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention.
    Burns DM
    Cancer; 2000 Dec; 89(11 Suppl):2506-9. PubMed ID: 11147637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lung cancer and indoor radon exposure in the north of Portugal--an ecological study.
    Veloso B; Nogueira JR; Cardoso MF
    Cancer Epidemiol; 2012 Feb; 36(1):e26-32. PubMed ID: 22075535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radon and lung cancer.
    Sethi TK; El-Ghamry MN; Kloecker GH
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):157-64. PubMed ID: 22402423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary lung cancer risk assessment of exposure to radon progeny for Transylvania, Romania.
    Truta-Popa LA; Dinu A; Dicu T; Szacsvai K; Cosma C; Hofmann W
    Health Phys; 2010 Sep; 99(3):301-7. PubMed ID: 20699690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Shelter and indoor air in the twenty-first century--radon, smoking, and lung cancer risks.
    Fabrikant JI
    Environ Health Perspect; 1990 Jun; 86():275-80. PubMed ID: 2401265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An overview of the North American residential radon and lung cancer case-control studies.
    Field RW; Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
    J Toxicol Environ Health A; 2006 Apr; 69(7):599-631. PubMed ID: 16608829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of media campaign promoting smoking cessation suggests it was cost-effective in prompting quit attempts.
    Villanti AC; Curry LE; Richardson A; Vallone DM; Holtgrave DR
    Health Aff (Millwood); 2012 Dec; 31(12):2708-16. PubMed ID: 23213155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of radon and smoking among Czech uranium miners.
    Tomasek L
    Radiat Prot Dosimetry; 2011 May; 145(2-3):238-42. PubMed ID: 21471126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.